Journal of Clinical Virology
Volume 29, Issue 3 , Pages 179-188 , March 2004

Design and performance testing of quantitative real time PCR assays for influenza A and B viral load measurement

  • C.L Ward

      Affiliations

    • International Clinical Virology, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44-1438-76-3917; fax: +44-1438-76-4263.
    • ,
  • M.H Dempsey

      Affiliations

    • Immunotherapeutics, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK
    • ,
  • C.J.A Ring

      Affiliations

    • Gene Interference, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK
    • ,
  • R.E Kempson

      Affiliations

    • GDO IS Statistical Services, GlaxoSmithKline, Park Road, Ware, Hertfordshire SG12 0DP, UK
    • ,
  • L Zhang

      Affiliations

    • International Clinical Virology, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK
    • ,
  • D Gor

      Affiliations

    • Clinical Development and Medical Affairs, Respiratory, GlaxoSmithKline, Stockley Park West, Uxbridge, Middlesex, UB11 1BU, UK
    • ,
  • B.W Snowden

      Affiliations

    • International Clinical Virology, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK
    • ,
  • M Tisdale

      Affiliations

    • International Clinical Virology, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK

Received 27 May 2002 ,Revised 28 April 2003 ,Accepted 6 May 2003.

References 

  1. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1999;25:3389–3402
  2. Barnett JM, Cadman A, Gor D, Dempsey M, Walters M, Candlin A, et al. Zanamivir susceptibility monitoring and characterisation of influenza virus clinical isolates obtained during phase II clinical efficacy studies. Antimicrob. Agents Chemother. 2000;44:78–87
  3. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet. 1998;351:472–477
  4. De Vries TJ, Fourkour A, Punt CJA, van de Locht LTF, Wobbes T, van den Bosch S, et al. Reproducibility of detection of tyrosine and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR. Br. J. Cancer. 1999;80:883–891
  5. Hayden FG, Palese P. Influenza virus. In:  Rickmann DD,  Whittey RJ,  Hayden FG editor. Clinical Virology. New York: Churchill Livingstone; 1997;
  6. Hayden FG, Treanor JJ, Betts RF, Lobo M, Esinhart JD, Hussey EK. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. J. Am. Med. Assoc. 1996;275:295–299
  7. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections. New Engl. J. Med. 1997;337:874–880
  8. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′ to 3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc. Natl. Acad. Sci. USA. 1991;88:7276–7280
  9. Kashiwagi S, Kudoh S, Watanabe A, Yoshimura I. Clinical efficacy and safety of the selective oral neuraminidase inhibitor oseltamivir in treating acute influenza—placebo-controlled double-blind multicenter phase III trial. Kansenshogaku Zasshi—J. Jpn. Assoc. Infect. Dis. 2000;74:1044–1061
  10. Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 1993;21:3761–3766
  11. Livak KJ, Flood SJ, Marmaro J, Giusti W, Deetz K. Oligonucleotides with fluorescent dyes at the opposite ends provide a quenched probe system useful for detecting PCR product and nucleic acid hybridisation. PCR Methods Appl. 1995;4:357–362
  12. Makela MJ, Pauksens K, Rostila T, Fleming DM, Man CY, Keene ON, et al. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomised, double-blind, placebo-controlled European study. J. Infect. 2000;40:42–48
  13. Monto AS, Moult AB, Sharp SJ. Effect of zanamivir on duration and resolution of influenza symptoms. Clin. Ther. 2000;22:1294–1305
  14. Peccoud J, Jacob C. Theoretical uncertainty of measurements using quantitative polymerase chain reaction. Biophys. J. 1996;71:101–108
  15. Puhakka T, Lehti H, Vainionpaa R, Jormanainen V, Pulkkinen M, Sharp S, et al. Zanamivir: a significant reduction in viral load during treatment in military conscripts with influenza. Scand. J. Infect. Dis. 2003;35:52–58
  16. Schweiger B, Zadow L, Heckler R, Timm H, Pauli G. Application of a fluorogenic PCR assay for typing and subtyping of influenza viruses in respiratory samples. J. Clin. Microbiol. 2000;38:1552–1558
  17. Stockton J, Ellis JS, Saville M, Clewley JP, Zambon MC. Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J. Clin. Microbiol. 1998;36:2990–2995
  18. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomised controlled trial. US Oral Neuraminidase Study Group. J. Am. Med. Assoc. 2000;283:1016–1024
  19. van Elden LJ, Nijhuis M, Schipper P, Schuurman R, van Loon AM. Simultaneous detection of influenza viruses A and B using real-time quantitative PCR. J. Clin. Microbiol. 2001;39:196–200
  20. Waner JL, Todd SJ, Shalaby H, Murphy P, Wall LV. Comparison of directigen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza virus. J. Clin. Microbiol. 1991;29:479–482

PII: S1386-6532(03)00122-7

doi: 10.1016/S1386-6532(03)00122-7

Journal of Clinical Virology
Volume 29, Issue 3 , Pages 179-188 , March 2004

Article Tools

* Image Usage & Resolution